Table 1 Assessment intervals for statural growth in CKD

From: Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease

Assessment type

Age (years)

Recommended intervals of assessment (months)

CKD stage 3

CKD stage 4

CKD stage 4–5

CKD stage 5D

Lengtha or height

0–1

0.5–2

0.5–2

0.5–2

0.5–2

1–3

1–3

1–2

1–2

1–2

>3

3–6

1–3

1–3

1–3

Length velocitya or height velocity

0–1

0.5–2

0.5–2

0.5–2

0.5–1

1–3

1–6

1–3

1–3

1–2

>3

6

6

6

6

  1. Recommendations were generated by combining those from the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines; the Caring for Australasians with Renal Impairment (CARI) guidelines; and the Clinical Guideline from the British Society for Paediatric Endocrinology and Diabetes (BSPED), the British Association for Paediatric Nephrology (BAPN) and the Paediatric Renal Interest Nutrition Group (PRING)11,15,16. CKD, chronic kidney disease. aSupine length is measured using a validated length board or mat up to a length of 80 cm (before 2 years of age) or if assessment of standing height is not feasible.
Back to article page